The HMG-domain transcription factor Sox10 is essential for the development of various neural crest derived lineages including glia and neurons of the peripheral nervous system (PNS). Within the PNS the most striking defect is the complete absence of glial differentiation whereas neurogenesis seemed initially normal. A degeneration of motoneurons and sensory neurons occurred later in development. The mechanism that leads to the dramatic effects on the neural crest derived cell lineages in the dorsal root ganglia (DRG), however, has not been examined up to now. Here, we provide a detailed analysis of proliferation and apoptosis in the DRG during the time of their generation and lineage segregation (between E 9.5 and E 11.5). We show that both increased apoptosis as well as decreased proliferation of neural crest cells contribute to the observed hypomorphism. q
Introduction
Various Sox proteins play important roles during development (Pevny and Lovell-Badge, 1997; Wegner, 1999) . They participate in diverse developmental processes from gastrulation and neurulation (Hudson et al., 1997; Mizuseki, 1998a,b) to haematopoiesis, sex determination, chondrogenesis, lens and neural crest development as well as formation of the nervous and vascular systems (e.g. Gubbay et al., 1990; Sinclair et al., 1990; Foster et al., 1994; Wagner et al., 1994; Schilham et al., 1996; Herbarth et al., 1998; Nishiguchi et al., 1998; Pingault et al., 1998; Southard-Smith et al., 1998) . Up to date more than 20 different Sox proteins have been identified in mammals that can be grouped into seven subfamilies and exhibit unique, but overlapping expression patterns (Wegner, 1999) . Sox10 belongs to the well-studied group E and is first ubiquitously expressed in the neural crest and later in various neural crest derivatives and glia (likely oligodendrocytes) of the central nervous system (CNS) .
Neural crest development has been intensely studied over the years (for review see Le Douarin and Kalcheim, 1999) . The neural crest is a transiently existing population of highly mobile cells that arise from the dorsal aspect of the neural tube. From there they migrate on defined routes through the embryo and give rise to such diverse structures as facial mesenchyme, melanocytes, neuroendocrine cells, peripheral glia and most neurons of the peripheral nervous system (PNS). Several genes have been identified that affect the development of the neural crest or some of its derivatives. Among them are transcription factors like Pax-3, mi and Sox10 (Epstein et al., 1991; Hodgkinson et al., 1993; Herbarth et al., 1998; Southard-Smith et al., 1998; Bondurand et al., 2000; Lang et al., 2000) . Another large group is formed by receptors and their ligands like GDNF, c-ret and the coreceptor GFRa (Schuchardt et al., 1994; Sanchez et al., 1996; Cacalano et al., 1998) , endothelin-3 (edn-3) and its receptor endothelin receptor B (EdnrB) Hosoda et al., 1994) , steel, its receptor the tyrosine kinase c-kit (Geissler et al., 1988; Williams et al., 1990 ) and the neuregulin-signalling system (Lee et al., 1995; Meyer and Birchmeier, 1995; Erickson et al., 1997; Riethmacher et al., 1997; Britsch et al., 1998; Morris et al., 1999; Woldeyesus et al., 1999) . Mutations in some of these genes have been reported in humans where defects of c-ret lead to Hirschsprung disease (Edery et al., 1994; Romeo et al., 1994) , mutations of mi and Pax-3 lead to Waardenburg syndrome (Tassabehji et al., 1992; Hughes et al., 1994; Tachibana et al., 1994) and mutations in Edn-3 and EdnrB lead to a combination of both (Puffenberger et al., 1994; Edery et al., 1996; Hofstra et al., 1996) . These diseases are characterized by aganglionosis or by hearing deficits and pigmentation defects or by a combination of both. Sox10 mutations were found in the spontaneous mouse mutant Dominant megacolon (Dom) Southard-Smith et al., 1998) and human patients , where they cause Waardenburg/Hirschsprung syndrome. In rare cases, there is additional evidence of myelinopathies in patients with Sox10 mutations (Inoue et al., 1999; Southard-Smith et al., 1999; Touraine et al., 2000) . Most of these mutations are nonsense or frameshift mutations of a single allele, in Dom mice it is the latter one, thus leading to a shortened Sox10 protein SouthardSmith et al., 1998) . The observed defects caused by haploinsufficiency correlate well with the expression pattern of Sox10. Expression of Sox10 can be detected in all neural crest cells when they are generated and is maintained in several lineages later in development or up to adulthood. Among the neural crest derivatives that show transient or permanent Sox10 expression are melanocytes, peripheral glia and cells of the enteric nervous system Kuhlbrodt et al., 1998; Pusch et al., 1998; Southard-Smith et al., 1998) . We generated a null-allele of Sox10 by targeted mutagenesis that recapitulates the phenotypes of the Dom mouse (Britsch et al., 2001) . In a homozygous state, which has never been described in humans, Sox10 deficiency causes lethality either late during embryogenesis or perinatally (Southard-Smith et al., 1998; Britsch et al., 2001) . The pigmentation defects are more pronounced when compared to the heterozygotes while enteric aganglionosis concerns the entire intestine and stomach. Additionally, cranial ganglia, the sympathetic nervous system and dorsal root ganglia (DRG) are hypomorphic Southard-Smith et al., 1998; Kapur, 1999; Britsch et al., 2001) . These severe disturbances in PNS development are sufficient to explain the perinatal death. In these mutants a complete absence of glial differentiation in the PNS was observed, that established Sox10 as key regulator of peripheral gliogenesis (Britsch et al., 2001 ).
Here we report the detailed analysis of DRG development in Sox10 mutant embryos. We precisely determined proliferation and apoptosis during early DRG development (9.5 and 11.5 dpc) by incorporation of bromodeoxyuridine (BrdU) and TUNEL assay, respectively. We made use of the lacZ marker gene that replaces the complete open reading frame of Sox10 in the null-allele and reflects the Sox10 expression pattern (Britsch et al., 2001) , and compared it to that of other neural crest markers such as p75 LNGFR (low affinity nerve growth factor receptor) and cadherin-6 (Stemple and Anderson, 1991; Inoue et al., 1997) . Regarding proliferation, subtle differences became obvious on 9.5 dpc while on 10.5 dpc there is a strong increase in apoptotic cells and in parallel a dramatic decrease in proliferation. Both effects are strongly reduced on 11.5 dpc, the earliest time point, where differences become obvious by morphological analysis. This rather narrow time window is surprising as the resulting effect, cell number reduction of almost 80% on 12.5 dpc, is dramatic. Interestingly, cells within mutant DRG express either neuronal markers or lacZ but never both markers together demonstrating that Sox10 expression in neural crest cells is extinguished as they differentiate towards the neuronal lineage. BFABP, in the PNS a marker for glial cells, is never expressed in mutant ganglia. So there is a complete block of gliogenesis in Sox10 mutants. At later stages, the remaining cells within the rudimentary DRG mainly express lacZ and by morphology resemble undifferentiated precursor cells.
Results

Expression of the lacZ marker gene in heterozygous and homozygous Sox10 mutant mice
To inactivate the Sox10 gene the open reading frame was replaced with a lacZ marker. We have shown that at 8.5 dpc lacZ staining of homozygous and heterozygous embryos was indistinguishable, thus, on a gross morphological level initial formation of the neural crest was normal (Britsch et al., 2001) . To analyse the expression pattern of the lacZ marker in the developing DRG in detail, we performed lacZ staining on vibratome sections of heterozygous and homozygous embryos. On 8.5 dpc, expression of the lacZ marker was detected in cells of the forming neural crest in rostral parts of the closing neural tube. On 9.5 dpc, many lacZ positive neural crest cells had already delaminated and migrated through the embryo to generate dorsal root and sympathetic chain ganglia (Fig. 1 ). Only few neural crest cells still migrating on the ventral path are found at dorsal positions (Fig. 1A,B arrows) . The same structures also expressed Sox10 in heterozygous and wildtype embryos as evident from in situ hybridization (data not shown). In contrast to 8.5 dpc, when no differences between homozygous and heterozygous embryos were apparent at 9.5 dpc the sympathetic nervous system is already hypoplastic (Fig. 1A,B asterisks) . At 10.5 dpc the differences became stronger. LacZ positive cells were severely reduced in the area of the dorsal aorta where sympathetic chain ganglia are forming (not shown) and the boundaries of DRG that are still normal in size in homozygous mutant embryos seemed slightly distorted compared to the controls (Fig. 1D arrowheads). As Sox10 is strongly expressed in Schwann cells aligning all peripheral nerves, lacZ staining became widely distributed throughout the heterozygous embryo concomitant with the spreading of sensory and motor nerves into the periphery (Britsch et al., 2001) . In homozygotes, lacZ staining was already severely reduced along peripheral nerves (data not shown and Fig. 5 ). There was also significant staining in heterozygotes in the subcutaneous area that stems from melanocyte precursors migrating along the dorsolateral pathway (Fig. 1C, arrows) . No cells staining for lacZ were ever seen in homozygous embryos in that area ( Fig. 1) . At 11.5 dpc the signal aligning axonal projections was drastically reduced in the homozygous Sox10 mutant. In close vicinity to the DRG and ventral root some lacZ positive cells can be found (Fig. 1E,F and data not shown). In the ventral zone of the spinal cord where oligodendrocytes are generated at that stage of development lacZ positive cells were present. In mutant embryos the staining was normally located compared to the heterozygous, but was more intense reflecting the difference between two versus one copy of the lacZ marker gene in the respective genotype (Fig. 1E,F asterisk) . At 11.5 dpc the DRG were already dramatically smaller. In mutant embryos the ganglia were not clearly defined (Fig. 1F arrowheads) and cells were leaving the community especially towards the ventral roots. Mutant ganglia were split in two domains, one at a dorsal position that is comparable to a normal dorsal location of the ganglia and one ventral domain that seemed extended a bit ventrally compared to control ganglia. Between these two domains there were only few cells (Fig. 1F) .
Histology of DRG
To examine the morphological changes of the DRG in more detail we made semithin section of different embryonic stages. At 9.5 dpc the DRG are a mass of cells located between the spinal cord and the somites ( Fig. 2A,B) . In mutant embryos the ganglia appeared normal in size, integrity and location. At 10.5 dpc the ganglia were still normal in size but subtle changes became apparent. The ganglia were at a more medial position in close contact with the spinal cord (Fig. 2C,D) . The cells of the ganglia did not seem to be separated from the surrounding tissue as in the controls. This became even more pronounced at 11.5 dpc. To examine the absence of a precise outer border in more detail we performed an immunohistochemical analysis employing anti-laminin-antibodies. We found no difference comparing wildtype and mutant at 10.5 dpc when a basement membrane around the DRG has not been completed (Fig. 3A,B) . At 11.5 dpc wildtype ganglia were enclosed by a basement membrane while in mutant ganglia the surrounding membrane was only rudimentary (Fig. 3C,D) and hence explains the lack of separation between DRG and surrounding tissue.
Moreover, at 11.5 dpc mutant ganglia were significantly smaller and had a longitudinal shape compared to a round shape of the control ganglia. The already observed partition in a ventral and a dorsal domain was also evident from histological examination. In the dorsal domain numerous cells were found in the marginal zone near the dorsal root entry zone indicating that this latter structure was affected in the Sox10-deficient embryos (Fig. 2E,F) . From the fact that the lacZ marker was detected in some of these cells (data not shown) and by their morphology (Fig. 2F arrowhead) it can be concluded that some were neural crest cells or cells of neural crest origin migrating into the neural tube. These cellular bridges were only occasionally observed at ventral positions, never in the region between these two domains. The ventral domain never formed a clear boundary and cells with neuronal morphology were also found in the ventral roots.
Expression of marker genes in DRG
To extend the histological analysis of DRG, we next performed in situ hybridizations and immunofluorescence analysis. Cadherin-6, for instance, is widely expressed at 10.5 dpc in neural crest derivatives that contribute to the forming PNS (Inoue et al., 1997) . When we analysed transverse sections by in situ hybridization we found many cells positive for cadherin-6 within the DRG as well as some cells along the nerve in wildtype and heterozygous embryos ( Fig.  4A and data not shown). The cadherin-6 specific signal was very similar within the DRG when homozygous mutant embryos were analysed (Fig. 4B ). Cadherin-6 positive cells were also found in the ventral root in proximity of the ganglia but further distal cadherin-6 positive cells were missing from the nerve as expected from the histology. The lacZ staining was very similar to the cadherin-6 expression pattern, arguing for coexpression of both genes at this stage. At 12.5 dpc, cadherin-6 expression within the neural Fig. 3 . Immunohistochemical analysis of basement membrane formation around DRG in Sox10-deficient mice. Immunofluorescence analysis with a-laminin antibodies on transverse sections of wildtype (1/1 in A, C) and homozygous (2/2 in B, D) Sox10-deficient embryos at 10.5 dpc (A ,B) and 11.5 dpc (C, D) in the thoracic region. At 10.5 dpc a basement membrane around the neural tube is present in wildtype and mutant while the membrane around DRG is just about to be generated (A, B). Absence of a continuous basement membrane around the ganglia in mutant embryos at 11.5 dpc (D) present in the wildtype (C). Bar represents 50 mm (A, B) and 100 mm (C, D), respectively. Fig. 2 . Histology of DRG in Sox10-deficient mice. Transverse sections, 6 mm through the thoracic neural tube and DRG from 9.5 to 11.5 dpc embryos were stained with toluduine blue. Wildtype (1/1 in A, C, E) and homozygous Sox10-deficient embryos (2/2 in B, D, F). The arrowhead (F) marks the connection of DRG with dorsal neural tube. Bars represent 100 mm.
crest lineage becomes restricted to Schwann cells (Inoue et al., 1997) . Consequently, at this stage in wildtype and heterozygous embryos, DRG are mostly devoid of cadherin-6 positive cells with only a weak residual signal being detected in the ventralmost part. In agreement with the increase of Schwann cell numbers the staining along peripheral nerves became stronger (Fig. 4C) . At this developmental stage we now found a strongly divergent pattern in the homozygous embryos (Fig. 4D) . Staining along the peripheral nerves could not be detected as was expected and only a few positive cells were found in close vicinity to the ganglia. Interestingly, the cadherin-6 expression within the DRG, which by this age was already strongly reduced in size, was maintained. These cadherin-6 expressing cells were identical to the cells within the DRG of homozygous embryos that had a neural crest like appearance. Therefore, continued expression of cadherin-6 and morphology suggested that these cells are undifferentiated. Contrary to these dramatic changes of cadherin-6 expression in the periphery, CNS expression was fairly normal in homozygous embryos (Fig. 4D) .
To study the appearance of peripheral neurons, we used a probe for brn-3.0 because of its early appearance in DRG neurons after differentiation (Gerrero et al., 1993; McEvilly et al., 1996) . At 12.5 dpc, substantial numbers of differentiated neurons had appeared in the DRG of wildtype and heterozygous embryos (Fig. 4E) . In homozygous Sox10-deficient embryos, brn-3.0 positive cells were present in numbers reflecting the decreased size of the ganglia (Fig.  4F) . Nevertheless, neuronal differentiation had occurred in the DRG of homozygous embryos. Additionally, brn-3.0 positive cells outside the ganglia along outgoing nerves and in the ventral root area were occasionally found and correlated with the poorly defined demarcation of the DRG in the homozygous embryos (arrowheads Fig. 4F ).
Our in situ hybridization studies of DRG development were complemented by immunohistochemical analyses. Differentiated neurons within the DRG were visualized at 11.5 dpc by antibodies against neurofilament-160 (NF160) (Fig. 5A,B ,G,H), peripherin (Fig. 5C,D) and islet-1 (Fig.  5E,F) . With all three of these markers, differentiated neurons were detected in DRG of both heterozygous and homozygous embryos. The exact fluorescence patterns varied between these markers, as the detected proteins are localized in different compartments of the cells. When the same sections were colabelled with antibodies against lacZ and fluorescence patterns were compared, it became immediately obvious that fluorescence for lacZ and any of the neuronal markers was mutually exclusive in heterozygous embryos (Fig. 5A,C,E) . Thus, we conclude that lacZ (and by inference Sox10) is not expressed in cells of the neural crest once they adopt the neuronal phenotype.
The same conclusion was obtained, when immunofluorescence studies were carried out on sections of homozygous embryos (Fig. 5B,D,F) . Cells positive for the neuronal marker NF160, peripherin or islet-1 did not express lacZ and vice versa. Again these results demonstrated that in spite of the dramatic size reduction of the DRG neuronal differentiation does occur. In addition, cell somata positive for the neuronal marker peripherin were found in the dorsal and ventral roots of the spinal nerve of homozygous embryos ( Fig. 5D and Britsch et al., 2001) confirming the previous results from in situ hybridization with a brn-3.0 probe. As observed within the ganglia the peripherin positive cells outside the ganglia were also not labelled with the lacZ anti- body. In heterozygous or wildtype embryos, peripherin-positive cell bodies outside the CNS were restricted to the DRG (Fig. 5C ).
When we employed BFABP antibodies, that in the PNS are an early marker for satellite glia and Schwann cells (Britsch et al., 2001 ), we did not detect any BFABP signals outside the CNS in Sox10 mutant embryos (Fig. 5H) . So while neuronal differentiation did occur, glial differentiation was completely blocked.
As already mentioned, neural crest-derived cells extended into the ventral root region of homozygous Sox10-deficient mice. Beyond this point, almost no cells could be detected along nerves. Histological examination of somatic peripheral nerves bundles (e.g. those within the brachial plexus) revealed that there was a general reduction in fiber size, a slight disorganization and a severe defasciculation. Nevertheless, peripheral nerves were present and spinal ganglion cells of Sox10-deficient embryos extended their processes all the way into the subcutis or muscles as evidenced by serial sections (data not shown). However, none of these nerves was accompanied by significant numbers of Schwann cells (Fig. 6A,B ). This conclusion becomes even more compelling when comparable sections from 11.5 dpc old heterozygous and homozygous embryos were labelled with antibodies against neurofilament and lacZ. Immunofluorescence analysis of heterozygous animals demonstrated that the peripheral projections were studded with lacZ positive Schwann cells (Fig. 6C ) whereas comparable sections from homozygous embryos were devoid of lacZ signal (Fig. 6D) . Fig. 6 . Schwann cells in Sox10-deficient mice. Toluidine-blue stain of 6 mm plastic sections showing a representative peripheral nerve in control (A) and homozygous Sox10-deficient (B) embryos at 11.5 dpc. Arrowheads (A) mark Schwann cell precursors along the nerve. Immunofluorescence of peripheral nerves from heterozygous (1/2 in C) and homozygous Sox10-deficient (2/2 in D) embryos at 11.5 dpc with antibodies against NF-160 (NF, green) and against lacZ (red). Bars represent 25 mm. 
Expression of p75 LNGFR and lacZ in neural crest cells and developing DRG
p75
LNGFR is known to be expressed in neural crest cells when they are generated (Stemple and Anderson, 1991) . We have shown the same for Sox10 (Britsch et al., 2001 ). To demonstrate that both genes do not label different pools of neural crest cells, we performed a double immunofluorescence analysis with anti-p75 LNGFR -and anti-b-galactosidase antibodies on cryosections. The lacZ staining performed on vibratome sections (Fig. 1) showed a very strong expression of b-galactosidase in the whole DRG. However, it has to be kept in mind that our vibratome sections have a thickness of 100 mm (corresponding to approximately 15 cell layers), whereas the cryosections (8-10 mm thick) only span one to two cell layers.
At 8.75 to 9.5 dpc, antibodies against p75 LNGFR and bgalactosidase labelled migrating neural crest cells with comparable intensities and we found a near complete overlap between these two markers (Fig. 7A) . When we performed immunofluorescence analysis on sections of 10-11.5 dpc embryo sections we could observe that cells within the ganglia showed strongly variable expression levels, from high to non-expressing, for both marker genes (Fig. 7B,C) . Hence, in double immunofluorescence analysis from 10 dpc onwards the marker genes appeared to be coexpressed in many cells while also a substantial proportion of cells appeared positive for only one of the two markers (Fig.  6B) . High p75 LNGFR and high b-galactosidase expressing cells where in many cases mutually exclusive (Fig. 7B,C) . This became even more pronounced as the development proceeded (Fig. 7C) . It can be noted that cells singly expressing high levels of p75 LNGFR from 10 dpc on where located for the major part in the centre of the ganglia, while cells expressing high levels of lacZ and cells expressing both genes could be found mainly at the periphery of the ganglia. Cells strongly expressing both genes probably represent the precursor pool. From 10 dpc onwards, the high p75 LNGFR expressing cell pool is very likely comprised of cells committed for the neuronal lineage, while high expressing b-galactosidase, i.e. high Sox10 expressing cells will become glial cells. Interestingly, p75 LNGFR expression in glial cells within the ganglia (satellite glia) is relatively low compared to the higher expression in glial cells outside of the ganglia (Schwann cells).
Proliferation and apoptosis in DRG
Histological analysis had shown that DRG of homozygous embryos from 11 dpc on are reduced in size compared to wildtype and heterozygous embryos. To analyse the mechanism of this reduction in cell number we performed TUNEL-and BrdU-analysis on embryos between 9 and 11.5 dpc of development. These analyses were always accompanied by a colabelling with DAPI and either isl-1, p75 LNGFR -or lacZ antibodies. Early on 9 dpc, when neural crest cells have started to migrate out from the neural tube and a few hours later when they have just begun to form DRG, we found almost no apoptotic neural crest cells (as defined by simultaneous expression of p75 LNGFR -or b-galactosidase and TUNEL staining) in wildtype, heterozygous or homozygous embryos (Fig. 8A) . Only 24 h later this picture had dramatically changed. While still hardly any apoptotic cells were detected in the ganglia of wildtype and heterozygous embryos, in homozygous embryos about ten cells in 100 cells of the DRG were apoptotic (Fig. 8A-E) . Most apoptotic cells were either colabelled with lacZ or p75 LNGFR antibodies (Fig. 8B-D) . In contrast, we did not find apoptotic cells labelled with the isl-1 antibodies at this stage (Fig.  8E,H) . Interestingly, we found in experiments using lacZ or p75 LNGFR antibodies cells in the DRG that were apoptotic but not labelled by the antibodies (Fig. 8F,G) . On 11 dpc the naturally occurring cell death (NOCD) of cells in the ganglia had begun and we found two to four apoptotic cells per 100 cells in wildtype and heterozygous ganglia (Fig. 8A) . In homozygous embryos this rate was still increased by a factor of 3, but the main cell death occurred on 10 dpc in the DRG of homozygous animals when the rate was increased by a factor of 13 compared to wildtype and heterozygous. On 11 dpc we observed isl-1 positive apoptotic cells in controls and mutant, and although most of the apoptotic cells in the mutant were isl-1 negative the rate of isl-1 positive apoptotic cells was slightly increased compared to the controls. When we determined proliferation rates we found a slight difference between the three genotypes as early as 9 dpc (Fig. 9A) . Homozygous embryos displayed a 16% reduction compared to the wildtype already at 9 dpc. One day later, the reduction increased to 44% but decreased again to 30% at 11 dpc (Fig. 9A) . The colabelling of BrdU with either p75 LNGFR or lacZ identified the dividing cells as neural crest cells (Fig. 9B-E) . Interestingly, the proliferation rates from p75 LNGFR and lacZ positive cells were almost identical (not shown) and the BrdU labelling occurred mainly in the periphery of the ganglia. This suggested that dividing cells were mostly double positive. Higher magnification occasionally identified proliferating cells not positive for p75 LNGFR , most likely representing cells committed to the glial lineage (Fig. 9F,G arrowhead) . These experiments clearly demonstrate that proliferation deficits significantly contribute to the hypomorphism of the DRG in Sox10 mutant embryos and that the main effect is observed on 10 dpc. Interestingly, on 9 dpc ganglionic cells from heterozygous embryos displayed a 10% reduction compared to the wildtype. This deficit increased to 17% on 10 dpc and decreased again to 2% on 11 dpc (Fig. 9A) . When we compared apoptosis and proliferation rate in wildtype and heterozygous animals, we found a higher tendency for apoptosis in the ganglia of heterozygous compared to wildtype embryos. Although this small difference was consistent throughout the period analysed it was within the standard error and might therefore not be significant. However, differences in proliferation rates were statistically significant. The proliferation rate was significantly higher in ganglia from wildtype embryos compared to those of heterozygous. As this difference does not translate into a hypomorphism of DRG in heterozygous animals, it must be compensated later in development.
Discussion
It is well established that Sox10 plays important roles in a variety of neural crest derivatives in development and disease, i.e. melanocytes, enteric neurons, sympathetic neurons Pingault et al., 1998; Southard-Smith et al., 1998; Kapur, 1999) . We have previously shown that Sox10 in the PNS is absolutely required for the generation of glial cells (Britsch et al., 2001) . Later in development the absence of glial cells causes a severe hypomorphism of the DRG. This phenomenon was also observed in erbB3 and erbB2 deficient mice, however, the onset and degree of hypomorphism in these mice was later and less severe, respectively (Riethmacher et al., 1997; Woldeyesus et al., 1999) . In this paper, we present a detailed analysis of DRG development in heterozygous and homozygous Sox10 mutant embryos in comparison to wildtype Fig. 8 . Apoptosis in DRG between 9 and 11 dpc. Quantitative analysis of apoptosis in DRG was done on 10 mm transverse sections of wildtype, heterozygous and homozygous embryos in the thoracic region. Sections were counterstained with DAPI to visualize the nuclei and determine the absolute number of DRG cells per section. Average numbers of cells per section and DRG are: 9 dpc 12.5 (1/1), 13.5 (1/2) 11.5 (2/2); 10 dpc 135 (1/1), 133 (1/2), 122 (2/2); 11 dpc 281 (1/1), 248 (1/2), 149 (2/ 2). (A) Columns show average percentages of apoptotic (TUNEL labelled) cells referring to all cells (DAPI labelled) from DRG of wildtype (1/1), heterozygous (1/U) and homozygous (2/2) embryos between 9 and 11 dpc. embryos and identify the mechanisms causing the observed degeneration.
Histology and morphology
On the histological level we found no abnormalities in DRG development in the early phase, i.e. 8-10 dpc. On 10.5 dpc the ganglia normally become a distinct structure that is clearly separated from the surrounding tissue. In mutant embryos, cells were often found in loose association with the ganglia and not clearly separated from the neighbouring tissue. In agreement, a proper basement membrane is not generated around mutant ganglia. Especially from 11.5 dpc onwards cells leaving the ganglia towards the spinal cord and along the spinal nerve were frequently observed, arguing for a higher mobility or a decreased shielding from surrounding influences (i.e. attracting signals), or a combination of both. Also at this stage the severe hypomorphism of the ganglia that was undetectable by histological methods before became obvious.
Differentiation
The analysis of differentiation processes in the DRG revealed that the neuronal lineage was established. Neuronal differentiation was monitored by expression of the transcription factors brn-3.0 and isl-1, the structural proteins peripherin and neurofilament as well as by histology and seemed fairly normal. We were unable to determine whether the number of generated neurons was normal as they degenerate shortly after their differentiation. However, we have no indication that initially this pool is reduced, as on 10 dpc neuronal projections were equally thick in mutant and wildtype embryos and thus arguing for an initially equal number of neurons.
As we reported earlier, glial differentiation in Sox10 mutant embryos is completely blocked as demonstrated by the absence of BFABP protein (Britsch et al., 2001 ). When we used the early neural crest marker cadherin-6 we found a normal expression pattern early in development up to 10.5 dpc. Then cadherin-6 expression in the peripheral nervous system switches from being pan neural crest to Fig. 9 . Proliferation in DRG between 9 and 11 dpc. Quantitative analysis of proliferation in DRG was done on 10 mm transverse sections of wildtype, heterozygous and homozygous embryos in the thoracic region. Sections were counterstained with DAPI to visualize the nuclei and determine the absolute number of DRG cells per section. Average number of cells per section and DRG see being Schwann cell specific. As Schwann cells are not generated in Sox10 deficient embryos we did not detect cadherin-6 staining along peripheral nerves. Likewise, lacZ staining or labelling with anti-lacZ-antibodies was missing. Interestingly, on 12 dpc when cadherin-6 expression in the DRG is normally almost extinguished we found strong expression in mutant ganglia. In avian embryos neural crest stem cells disappear in DRG 2 days after completion of migration (Duff and Langtimm, 1991; Sextier-Sainte-Claire Deville, 1992) . This correlates well with the disappearance of cadherin-6 expression in murine wildtype ganglia. At this stage mutant ganglia are only 20% in size and consist of neurons and what appears to be developmentally arrested neural crest cells. These morphologically undifferentiated cells express lacZ (Sox10), p75 LNGFR and cadherin-6 as do younger neural crest cells indicating that they are arrested in development and persist. Later in development when the ganglia have almost completely degenerated they are mainly made up of these undifferentiated lacZ positive cells.
Proliferation and apoptosis
p75
LNGFR and Sox10 were used to label neural crest cells when apoptosis or proliferation was analysed. Initially both markers are expressed together in all neural crest cells. As both proteins are located in different cellular compartments and expression levels diverge, we did not find a complete overlap from 10 dpc onwards. We found that about 70-80% of the cells in the DRG show labelling for either of the proteins. However, many of those cells have low protein levels and might therefore have started to shut down expression of one of the two proteins. Immunohistological analysis employing both markers revealed that cells expressing both markers at high levels could be found mainly at the border of the ganglia, and most likely represent progenitor cells. Those cells expressing p75 LNGFR in high amounts, on the other hand, can be found mainly in the centre of the ganglia and seem to have adopted a neuronal identity. Those cells expressing lacZ and only weakly or no p75 LNGFR have already entered the glial lineage.
Apoptosis rates on 9 dpc are similar in all three genotypes. However, on 10 dpc in homozygous embryos there is a 13-fold increase in apoptosis compared to wildtype and heterozygous littermates. This high incidence of apoptosis on 10 dpc is surprising, as there are almost no differences evident when looking at histological sections of that period. On 11 dpc we also find an increase in apoptosis, but to a lesser extent. Additionally, we could observe a reduction of the proliferation ability in DRG cells of homozygous embryos from 9 dpc onwards. Again the main differences between mutant and controls were found on 10 dpc. This shows that not only apoptosis is responsible for the phenotype, but inhibition of proliferation is also a contributing cause. There is a sharp peak of apoptosis and reduction of proliferation on 10 dpc, which is a rather narrow time window considering the dramatic effect on DRG development. When comparing apoptosis rates between wildtype and heterozygous embryos, we found a small but consistent increase in heterozygous embryos. However, when taking the standard error into account, this difference is not significant. The picture is different when proliferation rates are analysed. We found a significant decrease in proliferation on 9 and 10 dpc in heterozygous embryos, leading to a transient reduction of cell numbers in DRG an 11 dpc (16%). Thus, Sox10 is important for the proliferation activity of neural crest cells in the DRG and even a reduction of expression levels to 50% has an influence on the proliferation rate. We do not know the exact details of Sox10's impact on proliferation. However, we like to point out that we have previously identified erbB3 as a Sox10 target gene (Britsch et al., 2001) . The neuregulin family of ligands and its receptors, erbB2-erbB3-erbB4, take over a variety of functions (Buonanno and Fischbach, 2001) . Neural crest derived glial precursors as well as neural crest cells require this signalling system for survival, migration and -importantly in this contextproliferation (Dong et al., 1995; Bannerman et al., 2000) . The serum response factor which is a transcription factor known to be generally involved in proliferation processes (Treisman and Ammerer, 1992 ) is another recently identified potential Sox10 target gene (M.W., unpublished). We cannot exclude that Sox10 regulates other genes influencing proliferation and survival of neural crest cells but clearly regulation of erbB3 and serum response factor could explain the observed phenotype.
In contrast to proliferation we did not observe a significant difference comparing apoptosis rates from wildtype and heterozygous embryos, however, a complete absence of Sox10 greatly influences the survival rate of DRG cells. It has also to be noted that the number of apoptotic cells were slightly higher in the lacZ positive pool on 10 dpc compared to the p75 LNGFR positive pool. One explanation could be that on 10 dpc mainly cells committed to the glial fate die, while on 11 dpc of development, when the rates are equal, more of the p75 LNGFR positive cells in the centre of the ganglia (neuronal lineage) start to die. This is in agreement with the lack of isl-1 positive apoptotic cells at 10.5 dpc and the later increase of these cells in Sox10 mutants compared to controls.
On 11 dpc, the majority of the BrdU positive, i.e. proliferating cells of the ganglia are found on the borders. This is in accordance with the data from Wakamatsu and Weston who also localized the undifferentiated, proliferating cells at the border of the ganglia (Wakamatsu et al., 2000) . It should be noted that this is also the region were we found most of the p75 LNGFR and lacZ ( ¼ Sox10) double positive cells. Here double positive cells expressed high amounts of both proteins and we conclude that the double positive cells are the progenitor cells, which still have retained the potential to proliferate. Our results show that the stronger hypoplasia of DRG in Sox10 mutant versus erbB3 or erbB2 mutant embryos is not only due to absence of satellite glia but also to the importance of Sox10 for proliferation.
Experimental procedures
4.1. In situ hybridization, immunohistochemistry, lacZ staining, histology and microscopy Embryos were isolated at 9.5-11.5 dpc from staged pregnancies and mildly fixed in 1% PFA at 48C for some hours up to overnight. Thereafter they were either equilibrated in 20% sucrose, embedded in OCT (Miles), frozen and cryosectioned or embedded in 2% agarose and then sliced on a vibratome. Immunohistochemistry was performed as described (Britsch et al., 1998) . Mouse monoclonal antibodies against islet-1 (Hybridoma Bank), NF-160 (Sigma) and lacZ (Roche Biochemicals) were used in addition to polyclonal antibodies against peripherin (Chemicon), BFABP (Kurtz et al., 1994) , lacZ (ICN), Laminin (Sigma) and p75 LNGFR (Promega) for immunohistochemistry. Antibodies against BFABP were used in a 1:5000 dilution, all others as recommended by the manufacturer. Secondary antibodies conjugated to Alexa (Molecular Probes) and Cy3 (Jackson Laboratories) immunofluorescent dyes were used for detection. In situ hybridization on vibratome slices was performed essentially as described (Wilkinson, 1992) with probes for cadherin-6 and brn-3.0. Staining for b-galactosidase activity was performed essentially as described (Hogan et al., 1994) . For histological analysis the embryos were fixed in 4% PFA for up to several days at 48C, dehydrated and embedded in Technovit 7100 resin (Kulzer); 6 mm sections were stained with toluidine blue.
Determination of proliferation and apoptosis rates of neural crest cells
BrdU (75 mg/g body weight) was injected into pregnant mice 1 h before sacrifice. Staged embryos were prepared for cryosectioning and consecutive sections covering the entire forelimb region were made. BrdU positive nuclei were identified using anti-BrdU antibodies (Sigma, monoclonal antibody BU-33). TUNEL-staining with the Apop-Tag kit (Oncor) was performed according to the manufacturer. In either case the sections were double stained with polyclonal antibodies against lacZ or p75 LNGFR . DAPI was used to visualize the nuclei enabling us to determine the absolute number of cells in developing DRG. The signals were analysed on a Zeiss-microscope, photographed with the Zeiss axiocam. Cells were classified as proliferating or apoptotic when the signal was overlapping with the DAPI counterstain and were additionally monitored for existence of overlapping, surrounding or very closely associated staining of isl-1, lacZ or p75 LNGFR . For each genotype three to six embryos and five to six DRG per embryo were analysed. Statistical analysis was performed using KaleidaGraph (Synergy Software).
